Plain-English translation of NCT06650826 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is looking for a specific type of antibody in the blood that may be linked to unusual blood clots in younger adults. Researchers want to understand how often these antibodies appear in people who have experienced blood clots that happened suddenly, after an infection or vaccination, or that keep recurring even while taking blood-thinning medications. A single blood sample taken within 120 days of your clot will help answer these questions.
Doctors have noticed that some younger, otherwise healthy people develop dangerous blood clots in unusual circumstances—sometimes after infections or vaccinations, or even while taking medications meant to prevent clots. Understanding whether specific antibodies trigger these clots could help doctors identify at-risk patients earlier and develop better treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will visit the study site once within 120 days of your blood clot to have a single blood sample drawn. The researchers will also review your medical records to gather information about your blood clot, your platelet count, and results of any clotting screening tests you have had. The entire process is straightforward and non-invasive—just a blood draw and a brief conversation about your medical history.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Germany